Cerevel Therapeutics Holdings, Inc. - FORM S-1/A - EX-99.3 - EXHIBIT 99.3 - May 29, 2020

Attached files

file filename
S-1/A - S-1/A - Cerevel Therapeutics Holdings, Inc.nt10009663x4_s1a.htm
EX-23.1 - EXHIBIT 23.1 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex23-1.htm
EX-10.8 - EXHIBIT 10.8 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex10-8.htm
EX-10.7 - EXHIBIT 10.7 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex10-7.htm
EX-10.6 - EXHIBIT 10.6 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex10-6.htm
EX-10.5 - EXHIBIT 10.5 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex10-5.htm
EX-10.4 - EXHIBIT 10.4 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex10-4.htm
EX-10.3 - EXHIBIT 10.3 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex10-1.htm
EX-5.2 - EXHIBIT 5.2 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex5-2.htm
EX-5.1 - EXHIBIT 5.1 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex5-1.htm
EX-4.4 - EXHIBIT 4.4 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex4-4.htm
EX-4.3 - EXHIBIT 4.3 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex4-3.htm
EX-4.2 - EXHIBIT 4.2 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex4-2.htm
EX-4.1 - EXHIBIT 4.1 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex4-1.htm
EX-3.2 - EXHIBIT 3.2 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex3-2.htm
EX-3.1 - EXHIBIT 3.1 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex3-1.htm
EX-1.1 - EXHIBIT 1.1 - Cerevel Therapeutics Holdings, Inc.nt10009663x4_ex1-1.htm
Exhibit 99.3

CONSENT OF CHAD ROBINS
 
ARYA Sciences Acquisition Corp II (the “Company”) intends to file a Registration Statement on Form S-1(together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named in the Registration Statement as a Director Nominee.
 
May 29, 2020
 
 
By:
/s/ Chad Robins
  
 
Name:
Chad Robins
 

Cerevel Therapeutics Holdings, Inc. Reports